Skip to Main Content

Paper Details

Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma.
Cancer Res
36
2018
Author NameAffiliation
Chitra VenugopalStem Cell and Cancer Research Institute, McMaster University
Chirayu ChokshiStem Cell and Cancer Research Institute, McMaster University
Kevin R BrownUniversity of Toronto
Jason MoffatUniversity of Toronto
Sachdev S SidhuUniversity of Toronto
Sheila K SinghStem Cell and Cancer Research Institute, McMaster University
Sheila K SinghMcMaster University
  • 1 - 7

Datasets

Release 1.2